Keywords
Affiliated Institutions
Related Publications
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡
Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease for which there is no known effective therapy. A proportion of patients with NASH progress to advanced fibr...
Nonalcoholic Steatohepatitis in Children
Nonalcoholic steatohepatitis occurs in children, is clinically diverse, and may not be benign.
Nonalcoholic Steatohepatitis in Children
ABSTRACT Background: Nonalcoholic steatohepatitis occurs commonly in adults with obesity or diabetes mellitus. There are only a few reports of this condition in children. Method...
Non‐alcoholic steatohepatitis: What is it, and why is it important in the Asia–Pacific region?
Abstract Non‐alcoholic steatohepatitis (NASH), is a critical link in the chain of metabolic fatty liver disorders that spans steatosis to cryptogenic cirrhosis. It is the hepati...
Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
Aliment Pharmacol Ther 2011; 34: 274–285 Summary Background Non‐alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence co...
Publication Info
- Year
- 2002
- Type
- review
- Volume
- 16
- Issue
- 5
- Pages
- 749-765
- Citations
- 57
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1053/bega.2002.0331